Publication:

Basal-bolus insulin therapy during switching over from continuous intra venous regular insulin to sub cutaneous insulin therapy as compared to conventional regimens in type-2 diabetes patients admitted

Background According to the World Health Organization (WHO), over 347 million people worldwide have diabetes. Latest estimates reveal that 25.4 million Americans have diabetes mellitus (DM), with up to 95% of those having type 2 DM. This study was done to know the effects of Glargine insulin plus human regular insulin on blood sugar control while switching over from continuous IV insulin infusion to SC route as compared to conventional SC insulin regimens in CCU setup.

Methods 65 patients of T2DM were included this study. Detailed history, physical examination and relevant systemic examination were performed and necessary lab investigations were done.

Results The mean age was 49.52±10.16. Mean FPG on 1st Day: The p value of B-B against PRE is significant. Mean FPG on Day of discharge: The p value of B-B against PRE is significant and B-B against NPH is also significant. Mean FPG 2Weeks after discharge: The p value of B-B against PRE is significant and B-B against NPH is also significant. Mean PPPG on 1st Day: The p value of B-B against NPH is significant. Mean PPPG on day of discharge: The p value of B-B against PRE is significant. Mean PPPG 2weeks after discharge: The p value of B-B against PRE is significant. Hypoglycemia was occurring in 25, 15, and 25 in BB, NPH, and PRE group respectively. The p value is significant when NPH compared to PRE.

Conclusions B-B regimen was better than other regimen for controlling FPG and PPPG. The insulin dose was high in NPH regimen compared to both B-B and PRE regimens.